Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
Eugenia D. Namiot, Aleksandr V. Sokolov, Vladimir N. Chubarev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 787-787
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

New opportunities and old challenges in the clinical translation of nanotheranostics
Peter J. Gawne, Miguel Ferreira, Marisa Papaluca, et al.
Nature Reviews Materials (2023) Vol. 8, Iss. 12, pp. 783-798
Closed Access | Times Cited: 55
Biologics, theranostics, and personalized medicine in drug delivery systems
Matteo Puccetti, Marilena Pariano, Aurélie Schoubben, et al.
Pharmacological Research (2024) Vol. 201, pp. 107086-107086
Open Access | Times Cited: 41
A careful look at lipid nanoparticle characterization: analysis of benchmark formulations for encapsulation of RNA cargo size gradient
Gretchen B. Schober, Sandra Story, Dev P. Arya
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Microfluidic synthesis of lipid-based nanoparticles for drug delivery: recent advances and opportunities
Sima Mehraji, Don L. DeVoe
Lab on a Chip (2024) Vol. 24, Iss. 5, pp. 1154-1174
Open Access | Times Cited: 16
Liposomes characterization for market approval as pharmaceutical products: Analytical methods, guidelines and standardized protocols
Stefano Giordani, Valentina Marassi, Andrea Zattoni, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 236, pp. 115751-115751
Open Access | Times Cited: 35
Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers
Md Abdus Subhan, Nina Filipczak, Vladimir P. Torchilin
Pharmaceuticals (2023) Vol. 16, Iss. 7, pp. 970-970
Open Access | Times Cited: 27
The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment
Vivian Andoh, Dickson Kofi Wiredu Ocansey, Hassan Naveed, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6099-6126
Open Access | Times Cited: 10
Nanometrics goes beyond the size: Assessment of nanoparticle concentration and encapsulation efficiency in nanocarriers
Sara S. Marques, Marcela A. Segundo
TrAC Trends in Analytical Chemistry (2024) Vol. 174, pp. 117672-117672
Open Access | Times Cited: 7
161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer
Evangelia-Alexandra Salvanou, Adamantia Apostolopoulou, Stavros Xanthopoulos, et al.
Materials (2025) Vol. 18, Iss. 2, pp. 248-248
Open Access
Editorial for Special Issue “Effects of Nanoparticles on Living Organisms 2.0”
Yoshitaka Miyamoto
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 46-46
Open Access
Pathophysiology of IBD as a Key Strategy for Polymeric Nanoparticle Development
Elena Gardey, Johannes C. Brendel, Andreas Stallmach
Advanced Therapeutics (2025)
Open Access
Phytochemical-based nanosystems: recent advances and emerging application in antiviral photodynamic therapy
Yan Shan Loo, Nur Aininie Yusoh, Wai Feng Lim, et al.
Nanomedicine (2025), pp. 1-16
Closed Access
Lipid Nanoparticles Carrying Essential Oils for Multiple Applications as Antimicrobials
Elenice Francisco da Silva, Fernanda Aparecida Longato dos Santos, Henrique Machado Pires, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 178-178
Open Access
Nanomedicine and Its Role in Surgical Wound Infections: A Practical Approach
Malak Bentaleb, Mohammed Abdulrahman, Marcelo Augusto Fontenelle Ribeiro
Bioengineering (2025) Vol. 12, Iss. 2, pp. 137-137
Open Access
Advances in techniques to characterize cell-nanomaterial interactions (CNI)
Xingyue Huang, Xianlei Li, Andy Tay
Nano Today (2024) Vol. 55, pp. 102149-102149
Closed Access | Times Cited: 5
Flavonoids derived from medicinal plants as a COVID‐19 treatment
Mentor Sopjani, Francesca Falco, Federica Impellitteri, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1589-1609
Open Access | Times Cited: 5
Multi-functional nanomedicines for combinational cancer immunotherapy that transform cold tumors to hot tumors
Hanhee Cho, Kwangmeyung Kim
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 4, pp. 627-638
Closed Access | Times Cited: 5
Current RNA strategies in treating cardiovascular diseases
Shirley Pei Shan Chia, Jeremy Kah Sheng Pang, Boon-Seng Soh
Molecular Therapy (2024) Vol. 32, Iss. 3, pp. 580-608
Open Access | Times Cited: 4
Cannabidiol-Loaded Solid Lipid Nanoparticles Ameliorate the Inhibition of Proinflammatory Cytokines and Free Radicals in an In Vitro Inflammation-Induced Cell Model
Khent Primo Alcantara, John Wilfred T. Malabanan, Nonthaneth Nalinratana, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4744-4744
Open Access | Times Cited: 4
Recent advanced lipid-based nanomedicines for overcoming cancer resistance
Piroonrat Dechbumroong, Runjing Hu, Wisawat Keaswejjareansuk, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 3
Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer
Sona Gandhi, Indrajit Roy
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1457-1457
Open Access | Times Cited: 10
Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases
Asmaa Khalil, Alexandre Barras, Rabah Boukherroub, et al.
Nanoscale Horizons (2023) Vol. 9, Iss. 1, pp. 14-43
Open Access | Times Cited: 8
The Synthesis and Characterization of a Delivery System Based on Polymersomes and a Xanthone with Inhibitory Activity in Glioblastoma
Ana Catarina Alves, Ana Margarida Silva, Cláudia Nunes, et al.
Life (2024) Vol. 14, Iss. 1, pp. 132-132
Open Access | Times Cited: 2
Tailored Viral-Like Particles as Drivers of Medical Breakthroughs
Rafael Travassos, Sofia A. Martins, Ana Fernandes, et al.
(2024)
Open Access | Times Cited: 2
Nanoparticle-neutrophils interactions for autoimmune regulation
Daniel Kupor, Michael L. Felder, Shivanie Kodikalla, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115316-115316
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top